1. Home
  2. FWRD vs VIR Comparison

FWRD vs VIR Comparison

Compare FWRD & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$16.71

Market Cap

512.4M

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.96

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
VIR
Founded
1981
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.4M
1.5B
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
FWRD
VIR
Price
$16.71
$8.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$38.50
$19.63
AVG Volume (30 Days)
755.0K
2.8M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
88.54
17.49
EPS
N/A
N/A
Revenue
$1,269,573,000.00
$68,556,000.00
Revenue This Year
$6.57
N/A
Revenue Next Year
$6.66
$1,049.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.79
$4.16
52 Week High
$32.47
$10.91

Technical Indicators

Market Signals
Indicator
FWRD
VIR
Relative Strength Index (RSI) 35.41 50.96
Support Level $15.28 $8.67
Resistance Level $30.48 $10.29
Average True Range (ATR) 0.95 0.46
MACD 0.25 -0.15
Stochastic Oscillator 58.20 40.57

Price Performance

Historical Comparison
FWRD
VIR

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: